Dimerix granted Mexican patent for Phase II-ready kidney injury drug candidate | Stockhead

Dimerix (ASX:DXB) has been granted a composition of matter patent in Mexico for the newly acquired kidney drug candidate DMX-652.

Continue in Briflio to read, react, comment, and share.